Nicoletti, Tommaso Filippo
 Distribuzione geografica
Continente #
NA - Nord America 634
EU - Europa 383
AS - Asia 61
SA - Sud America 4
AF - Africa 3
OC - Oceania 3
Totale 1.088
Nazione #
US - Stati Uniti d'America 633
SE - Svezia 170
IT - Italia 54
PL - Polonia 32
IE - Irlanda 31
DE - Germania 27
FR - Francia 26
IN - India 20
CN - Cina 19
FI - Finlandia 19
GB - Regno Unito 11
HK - Hong Kong 6
IR - Iran 4
AT - Austria 3
BE - Belgio 3
VN - Vietnam 3
AU - Australia 2
CI - Costa d'Avorio 2
CO - Colombia 2
NL - Olanda 2
RO - Romania 2
BN - Brunei Darussalam 1
BR - Brasile 1
CA - Canada 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SG - Singapore 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.088
Città #
Chandler 200
Ashburn 48
Warsaw 32
Dublin 29
San Mateo 28
New York 26
Ann Arbor 22
Marseille 21
Wilmington 21
Princeton 19
Fairfield 18
Helsinki 17
Boston 16
Houston 12
Rome 11
Beijing 9
Pune 9
Woodbridge 8
Bremen 7
Jacksonville 7
Milan 7
Redwood City 7
Seattle 7
Hong Kong 6
Cambridge 4
Dearborn 4
Norwalk 4
Brussels 3
Dong Ket 3
Kish 3
Livorno 3
Los Angeles 3
Vittuone 3
Abidjan 2
Andover 2
Bogotá 2
Catania 2
Cattolica 2
Dallas 2
Lappeenranta 2
London 2
Meppel 2
Miami 2
Monza 2
Nanjing 2
Novara 2
Pesaro 2
Qingdao 2
San Diego 2
Vienna 2
Washington 2
Atlanta 1
Auckland 1
Augusta 1
Bandar Seri Begawan 1
Berlin 1
Bologna 1
Brisbane 1
Bristol 1
Campobasso 1
Changsha 1
Delhi 1
Edinburgh 1
Gunzenhausen 1
Gurgaon 1
Hefei 1
Hounslow 1
Izmir 1
Jakarta 1
Jinan 1
Kensington 1
Leawood 1
Lima 1
Nagold 1
Nanchang 1
Nova Iguaçu 1
Portland 1
Prilep 1
Salalah 1
Seoul 1
Shanghai 1
Shenyang 1
Stockholm 1
Tel Aviv 1
Timisoara 1
Winnipeg 1
Yokohama 1
Zanjan 1
Totale 690
Nome #
Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study 130
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy 79
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 78
Response to "Autosomal recessive axonal neuropathy caused by HINT1 mutation: New association of a psychiatric disorder to the neurological phenotype" 75
Application of a Clinical Workflow May Lead to Increased Diagnostic Precision in Hereditary Spastic Paraplegias and Cerebellar Ataxias: A Single Center Experience 70
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 68
Imaging Features of Varicella Zoster Virus Cranial Multiple Mononeuropathies 61
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 60
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 54
Muscle hypertrophy in amyloid myopathy 47
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 44
Myotonic dystrophy type 1 cosegregating with autosomal dominant polycystic kidney disease type 2 43
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 42
Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1) 41
Secondary hypokalemic periodic paralysis as a rare clinical presentation of Conn syndrome 40
NGS-based detection of a novel mutation in PRKCG (SCA14) in sporadic adult-onset ataxia plus dystonic tremor 40
Compound heterozygosity for an expanded (GAA) and a (GAAGGA) repeat at FXN locus: from a diagnostic pitfall to potential clues to the pathogenesis of Friedreich ataxia 38
Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis 38
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 38
Reply to the letter entitled “Predictors of respiratory impairment in patients with myotonic dystrophy type 1” 30
Totale 1.116
Categoria #
all - tutte 5.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202081 8 1 18 1 5 3 3 0 8 10 21 3
2020/2021130 5 4 7 4 13 4 30 7 12 18 20 6
2021/2022230 11 5 2 43 8 13 7 36 15 9 39 42
2022/2023504 57 60 24 81 29 62 27 56 64 11 28 5
2023/2024164 11 55 5 11 1 46 20 4 1 8 2 0
Totale 1.116